Reuben Ben-David, Yotam Veredgorn, Ziv Savin, Yuval Bar-Yosef, Ofer Yossepowitch, Mario Sofer, Roy Mano
{"title":"外源性恶性输尿管梗阻经串联输尿管支架治疗的简化预后模型的外部验证——一项回顾性队列研究。","authors":"Reuben Ben-David, Yotam Veredgorn, Ziv Savin, Yuval Bar-Yosef, Ofer Yossepowitch, Mario Sofer, Roy Mano","doi":"10.1080/21681805.2023.2171113","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Prognostic models of survival can identify patients with extrinsic malignant ureteral obstruction who will benefit from long-term drainage as offered by tandem ureteral stents. The study aims to validate a simplified prognostic model published by Cordeiro et al. and to identify additional prognostic predictors in a cohort of patients drained solely with tandem ureteral stents.</p><p><strong>Methods: </strong>Medical records of consecutive patients who underwent drainage of malignant ureteral obstruction with tandem ureteral stents between 2007 and 2020 were reviewed retrospectively; patients with benign ureteral obstruction were excluded. Risk factors for survival included were: [1] the number of malignancy-related events (categorized as ≥4 and <4) and [2] the Eastern Cooperative Oncology Group Index (categorized as ≥2 and <2)]. Patients with ≥1 risk factor were grouped as intermediate-unfavorable risk and those without risk factors as favorable risk. The Kaplan-Meier and log-rank tests were used for survival analysis. Univariable and multivariable Cox regression analyses were used to identify predictors of outcome.</p><p><strong>Results: </strong>The study cohort consisted of 65 patients; the median age was 60 years (IQR 51-72). The median follow-up time from diagnosis of hydronephrosis was 51 months (IQR 38-64). Estimated probabilities of survival at 1 month, 6 months 1 year, and 2 years were 100%, 87%, 75% and 57%, respectively in the favorable risk group (<i>n</i> = 40), and in the intermediate-unfavorable risk group (<i>n</i> = 25), 96%, 72%, 52%, and 20%, respectively, (<i>p</i> = .003). On multivariable analysis, the presence of ≥4 malignancy-related events (HR = 2.04, 95% CI [1.07-3.86], <i>p</i> = .03) and lung metastasis (HR = 2.37, 95% CI [1.0-5.6], <i>p</i> = .05) were associated with shorter survival.</p><p><strong>Conclusions: </strong>Our findings validate the prognostic model published by Cordeiro et al. The model can be applied when counseling patients being considered for drainage with tandem ureteral stents.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"90-96"},"PeriodicalIF":1.4000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"External validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents - a retrospective cohort study.\",\"authors\":\"Reuben Ben-David, Yotam Veredgorn, Ziv Savin, Yuval Bar-Yosef, Ofer Yossepowitch, Mario Sofer, Roy Mano\",\"doi\":\"10.1080/21681805.2023.2171113\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Prognostic models of survival can identify patients with extrinsic malignant ureteral obstruction who will benefit from long-term drainage as offered by tandem ureteral stents. The study aims to validate a simplified prognostic model published by Cordeiro et al. and to identify additional prognostic predictors in a cohort of patients drained solely with tandem ureteral stents.</p><p><strong>Methods: </strong>Medical records of consecutive patients who underwent drainage of malignant ureteral obstruction with tandem ureteral stents between 2007 and 2020 were reviewed retrospectively; patients with benign ureteral obstruction were excluded. Risk factors for survival included were: [1] the number of malignancy-related events (categorized as ≥4 and <4) and [2] the Eastern Cooperative Oncology Group Index (categorized as ≥2 and <2)]. Patients with ≥1 risk factor were grouped as intermediate-unfavorable risk and those without risk factors as favorable risk. The Kaplan-Meier and log-rank tests were used for survival analysis. Univariable and multivariable Cox regression analyses were used to identify predictors of outcome.</p><p><strong>Results: </strong>The study cohort consisted of 65 patients; the median age was 60 years (IQR 51-72). The median follow-up time from diagnosis of hydronephrosis was 51 months (IQR 38-64). Estimated probabilities of survival at 1 month, 6 months 1 year, and 2 years were 100%, 87%, 75% and 57%, respectively in the favorable risk group (<i>n</i> = 40), and in the intermediate-unfavorable risk group (<i>n</i> = 25), 96%, 72%, 52%, and 20%, respectively, (<i>p</i> = .003). On multivariable analysis, the presence of ≥4 malignancy-related events (HR = 2.04, 95% CI [1.07-3.86], <i>p</i> = .03) and lung metastasis (HR = 2.37, 95% CI [1.0-5.6], <i>p</i> = .05) were associated with shorter survival.</p><p><strong>Conclusions: </strong>Our findings validate the prognostic model published by Cordeiro et al. The model can be applied when counseling patients being considered for drainage with tandem ureteral stents.</p>\",\"PeriodicalId\":21542,\"journal\":{\"name\":\"Scandinavian Journal of Urology\",\"volume\":\"57 1-6\",\"pages\":\"90-96\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/21681805.2023.2171113\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21681805.2023.2171113","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 1
摘要
预后生存模型可以识别外源性恶性输尿管梗阻患者,这些患者将受益于串联输尿管支架提供的长期引流。该研究旨在验证Cordeiro等人发表的简化预后模型,并在仅采用串联输尿管支架引流的患者队列中确定其他预后预测因素。方法:回顾性分析2007 ~ 2020年连续行串联式输尿管支架引流恶性输尿管梗阻患者的病历;排除良性输尿管梗阻患者。影响生存的危险因素包括:[1]恶性肿瘤相关事件的数量(分类≥4)。结果:研究队列包括65例患者;中位年龄为60岁(IQR 51 ~ 72)。诊断为肾积水后的中位随访时间为51个月(IQR 38-64)。在有利风险组(n = 40), 1个月、6个月、1年和2年的估计生存率分别为100%、87%、75%和57%,在中等不利风险组(n = 25),分别为96%、72%、52%和20% (p = 0.003)。在多变量分析中,存在≥4个恶性相关事件(HR = 2.04, 95% CI [1.07-3.86], p = 0.03)和肺转移(HR = 2.37, 95% CI [1.0-5.6], p = 0.05)与较短的生存期相关。结论:我们的发现验证了Cordeiro等人发表的预后模型。该模型可应用于对考虑采用串联输尿管支架引流的患者进行咨询。
External validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents - a retrospective cohort study.
Introduction: Prognostic models of survival can identify patients with extrinsic malignant ureteral obstruction who will benefit from long-term drainage as offered by tandem ureteral stents. The study aims to validate a simplified prognostic model published by Cordeiro et al. and to identify additional prognostic predictors in a cohort of patients drained solely with tandem ureteral stents.
Methods: Medical records of consecutive patients who underwent drainage of malignant ureteral obstruction with tandem ureteral stents between 2007 and 2020 were reviewed retrospectively; patients with benign ureteral obstruction were excluded. Risk factors for survival included were: [1] the number of malignancy-related events (categorized as ≥4 and <4) and [2] the Eastern Cooperative Oncology Group Index (categorized as ≥2 and <2)]. Patients with ≥1 risk factor were grouped as intermediate-unfavorable risk and those without risk factors as favorable risk. The Kaplan-Meier and log-rank tests were used for survival analysis. Univariable and multivariable Cox regression analyses were used to identify predictors of outcome.
Results: The study cohort consisted of 65 patients; the median age was 60 years (IQR 51-72). The median follow-up time from diagnosis of hydronephrosis was 51 months (IQR 38-64). Estimated probabilities of survival at 1 month, 6 months 1 year, and 2 years were 100%, 87%, 75% and 57%, respectively in the favorable risk group (n = 40), and in the intermediate-unfavorable risk group (n = 25), 96%, 72%, 52%, and 20%, respectively, (p = .003). On multivariable analysis, the presence of ≥4 malignancy-related events (HR = 2.04, 95% CI [1.07-3.86], p = .03) and lung metastasis (HR = 2.37, 95% CI [1.0-5.6], p = .05) were associated with shorter survival.
Conclusions: Our findings validate the prognostic model published by Cordeiro et al. The model can be applied when counseling patients being considered for drainage with tandem ureteral stents.
期刊介绍:
Scandinavian Journal of Urology is a journal for the clinical urologist and publishes papers within all fields in clinical urology. Experimental papers related to clinical questions are also invited.Important reports with great news value are published promptly.